81 related articles for article (PubMed ID: 9269609)
1. A five-day course of dirithromycin in the treatment of acute exacerbation of severe chronic obstructive pulmonary disease.
Cazzola M; Caputi M; Santangelo G; Diu Vinciguerra A; Perna FD; Polverino M
J Chemother; 1997 Aug; 9(4):279-84. PubMed ID: 9269609
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary concentrations of dirithromycin and erythromycin during acute exacerbation of mild chronic obstructive pulmonary disease.
Matera MG; Tufano MA; Polverino M; Rossi F; Cazzola M
Eur Respir J; 1997 Jan; 10(1):98-103. PubMed ID: 9032500
[TBL] [Abstract][Full Text] [Related]
3. A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
Castaldo RS; Celli BR; Gomez F; LaVallee N; Souhrada J; Hanrahan JP
Clin Ther; 2003 Feb; 25(2):542-57. PubMed ID: 12749513
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
Cazzola M; Vinciguerra A; Di Perna F; Califano C; Calderaro F; Salzillo A; Centanni S
J Chemother; 1999 Apr; 11(2):119-25. PubMed ID: 10326742
[TBL] [Abstract][Full Text] [Related]
5. Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis.
Wasilewski MM; Johns D; Sides GD
J Antimicrob Chemother; 1999 Apr; 43(4):541-8. PubMed ID: 10350384
[TBL] [Abstract][Full Text] [Related]
6. A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis.
Hosie J; Quinn P; Smits P; Sides G
J Antimicrob Chemother; 1995 Jul; 36(1):173-83. PubMed ID: 8537264
[TBL] [Abstract][Full Text] [Related]
7. New drugs--reports of new drugs recently approved by the FDA. Dirithromycin.
Shinkai I; Ohta Y
Bioorg Med Chem; 1996 Apr; 4(4):521-2. PubMed ID: 8735838
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of dirithromycin in acute exacerbations of chronic bronchitis.
Sides GD
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():131-8. PubMed ID: 8478304
[TBL] [Abstract][Full Text] [Related]
9. A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitis.
Gaillat J
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():139-51. PubMed ID: 8478305
[TBL] [Abstract][Full Text] [Related]
10. Steady-state pharmacokinetics of theophylline in COPD patients treated with dirithromycin.
Bachmann K; Jauregui L; Sides G; Sullivan TJ
J Clin Pharmacol; 1993 Sep; 33(9):861-5. PubMed ID: 8227485
[TBL] [Abstract][Full Text] [Related]
11. [Dirithromycin in the treatment of infections of the lower respiratory tract].
Belousov IuB; Bykov AV; Komirova VP; Malikov VE; Minaev VI
Antibiot Khimioter; 1995 Jul; 40(7):35-8. PubMed ID: 8645058
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of dirithromycin in pneumonia.
Jacobson K
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():121-9. PubMed ID: 8478303
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary penetration of dirithromycin in patients suffering from acute exacerbation of chronic bronchitis.
Cazzola M; Matera MG; Tufano MA; Polverino M; Catalanotti P; Varanese L; Rossi F
Pulm Pharmacol; 1994 Dec; 7(6):377-81. PubMed ID: 7549225
[TBL] [Abstract][Full Text] [Related]
14. Dirithromycin in the treatment of skin and skin structure infections.
Derriennic M; Escande JP
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():159-68. PubMed ID: 8478307
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of dirithromycin in pharyngitis and tonsillitis.
Müller O; Wettich K
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():97-102. PubMed ID: 8478316
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of dirithromycin versus miocamycin in the treatment of acute bronchitis or acute exacerbations of chronic bronchitis.
Pozzi E
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():153-8. PubMed ID: 8478306
[TBL] [Abstract][Full Text] [Related]
17. Dirithromycin versus amoxiclav in the treatment of acute exacerbations of chronic bronchitis.
Van Royen P; Betz W; Heyrman J; Taziaux P; Van den Haute M; Poelman M
J Int Med Res; 1997; 25(1):33-40. PubMed ID: 9027671
[TBL] [Abstract][Full Text] [Related]
18. Tissue distribution of dirithromycin: comparison with erythromycin.
Bergogne-Bérézin E
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():77-87. PubMed ID: 8478314
[TBL] [Abstract][Full Text] [Related]
19. Dirithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.
Brogden RN; Peters DH
Drugs; 1994 Oct; 48(4):599-616. PubMed ID: 7528132
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of dirithromycin in patients with bacteremic pneumonia.
Hernández JM; Sides GD; Conforti PM; Smietana MG
Clin Ther; 1996; 18(6):1128-38. PubMed ID: 9001829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
